vedolizumabustekinumabICOicotrokinra6-MPAZAPBOulcerative colitis
… ≥2, and inadequate response/intolerance (IR) to TNFa blockers, vedolizumab, ustekinumab, JAK inhibitors, or S1P receptor modulators (BIO/J…
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ICO ×
ICO
This drug is selected. Its supporting articles are shown below.